_midostaurin-in-c-kit-or-flt3-itd-mutated-t821-aml-preview-1.jpg "Midostaurin in c-KIT or FLT3-ITD mutated t(8;21) AML from flt3 itd mutation positive Video Screenshot Preview 1")
Gallery_midostaurin-in-c-kit-or-flt3-itd-mutated-t821-aml-preview-3.jpg "Midostaurin in c-KIT or FLT3-ITD mutated t(8;21) AML from flt3 itd mutation positive Video Screenshot Preview 3")
Gallery_midostaurin-in-c-kit-or-flt3-itd-mutated-t821-aml-preview-hqdefault.jpg "Midostaurin in c-KIT or FLT3-ITD mutated t(8;21) AML from flt3 itd mutation positive Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 3 minutes 42 seconds
👁 View: 355 times
Play Audio:👁 View: 355 times
Description:
VJHemOnc – Video Journal of Hematology u0026 HemOnc
VJHemOnc – Video Journal of Hematology u0026 HemOnc
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_what-is-flt3-mutated-acute-myeloid-leukemia.webp "Patient Empowerment Network")
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.webp "Targeted Oncology")
_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_prognostic-impact-of-flt3-itd-in-older-patients-with-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_tangible-benefit-for-flt3-itd-r-r-aml-on-quizartinib.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_the-2021-treatment-algorithm-for-flt3-mutated-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_the-significance-of-flt3-mutations-in-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_sorafenib-for-flt3-itd-positive-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_what-is-flt3-mutated-acute-myeloid-leukemia.jpg)
_dr-rllig-on-flt3-itd-npm1-mutation-status-for-patients-with-aml.jpg)
_sf3b1-as-therapeutic-target-in-flt3-itd-positive-aml.jpg)
_prognostic-impact-of-flt3-itd-in-older-patients-with-aml.jpg)
_tangible-benefit-for-flt3-itd-r-r-aml-on-quizartinib.jpg)
_the-2021-treatment-algorithm-for-flt3-mutated-aml.jpg)
_the-significance-of-flt3-mutations-in-aml.jpg)
_sorafenib-for-flt3-itd-positive-aml.jpg)
![[+]](/images/menu.gif){kind=small}